? HSA Detected Slimming Products Offered Online Adulterated with Sibutramine
? Antipsychotics, Conventional and Atypical

? HAS Detected Slimming Products Offered Online Adulterated with Sibutramine
On 25-Jun-08, HSA issued a press release to warn general public to not to buy and consume a product offered online as “RELACORE”.
The product is detected to contain listed poisons “sibutramine” which is a listed Schedule 3 Poisons subject to the control of Medices and Poisons Act. In the interest of public health and safety, HSA is issuing this alert to the public not to purchase or consume this particular product. The full press release and the product pack shot of the suspected product is attached here.

?  Antipsychotics, Conventional and Atypical
On 16-Jun-08, USFDA notified healthcare professionals that both conventional and atypical antipsychotics are associated with an increased risk of mortality in elderly patients treated for dementia-related psychosis. In April 2005, FDA notified healthcare professionals that patients with dementia-related psychosis treated with atypical antipsychotic drugs are at an increased risk of death. Since issuing that notification, FDA has reviewed additional information that indicates the risk is also associated with conventional antipsychotics. Antipsychotics are not indicated for the treatment of dementia-related psychosis. The prescribing information for all antipsychotic drugs will now include the same information about this risk in a BOXED WARNING and the WARNINGS section. For more information, read here.

**********